Intrathecal analgesia for refractory cancer pain

Scott Newsome; Bridget K. Frawley; Charles E. Argoff

doi:10.1007/s11916-008-0043-0

Intrathecal analgesia for refractory cancer pain

Scott Newsome
, Bridget K. Frawley
, Charles E. Argoff

Research output: Contribution to journal › Review article › peer-review

26 Scopus citations

Abstract

The use of intrathecal analgesics is an important treatment consideration for many patients with chronic cancer pain. This review describes the various opioid and nonopioid analgesics that have been used in this setting, including morphine, hydromorphone, fentanyl, meperidine, methadone, sufentanil, local anesthetics, clonidine, ketamine, baclofen, midazolam, betamethasone, and octreotide. We discuss available evidence for their analgesic and adverse effects.

Original language	English (US)
Pages (from-to)	249-256
Number of pages	8
Journal	Current pain and headache reports
Volume	12
Issue number	4
DOIs	https://doi.org/10.1007/s11916-008-0043-0
State	Published - 2008
Externally published	Yes

ASJC Scopus subject areas

Clinical Neurology
Anesthesiology and Pain Medicine

Access to Document

10.1007/s11916-008-0043-0

Cite this

@article{b7123cbf976d4e2e8d1f3f5fa8e5ef09,

title = "Intrathecal analgesia for refractory cancer pain",

abstract = "The use of intrathecal analgesics is an important treatment consideration for many patients with chronic cancer pain. This review describes the various opioid and nonopioid analgesics that have been used in this setting, including morphine, hydromorphone, fentanyl, meperidine, methadone, sufentanil, local anesthetics, clonidine, ketamine, baclofen, midazolam, betamethasone, and octreotide. We discuss available evidence for their analgesic and adverse effects.",

author = "Scott Newsome and Frawley, \{Bridget K.\} and Argoff, \{Charles E.\}",

year = "2008",

doi = "10.1007/s11916-008-0043-0",

language = "English (US)",

volume = "12",

pages = "249--256",

journal = "Current pain and headache reports",

issn = "1531-3433",

publisher = "Springer",

number = "4",

}

TY - JOUR

T1 - Intrathecal analgesia for refractory cancer pain

AU - Newsome, Scott

AU - Frawley, Bridget K.

AU - Argoff, Charles E.

PY - 2008

Y1 - 2008

N2 - The use of intrathecal analgesics is an important treatment consideration for many patients with chronic cancer pain. This review describes the various opioid and nonopioid analgesics that have been used in this setting, including morphine, hydromorphone, fentanyl, meperidine, methadone, sufentanil, local anesthetics, clonidine, ketamine, baclofen, midazolam, betamethasone, and octreotide. We discuss available evidence for their analgesic and adverse effects.

AB - The use of intrathecal analgesics is an important treatment consideration for many patients with chronic cancer pain. This review describes the various opioid and nonopioid analgesics that have been used in this setting, including morphine, hydromorphone, fentanyl, meperidine, methadone, sufentanil, local anesthetics, clonidine, ketamine, baclofen, midazolam, betamethasone, and octreotide. We discuss available evidence for their analgesic and adverse effects.

UR - https://www.scopus.com/pages/publications/58149183079

UR - https://www.scopus.com/pages/publications/58149183079#tab=citedBy

U2 - 10.1007/s11916-008-0043-0

DO - 10.1007/s11916-008-0043-0

M3 - Review article

C2 - 18625101

AN - SCOPUS:58149183079

SN - 1531-3433

VL - 12

SP - 249

EP - 256

JO - Current pain and headache reports

JF - Current pain and headache reports

IS - 4

ER -

Intrathecal analgesia for refractory cancer pain

Abstract

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this